Myrto K. Moutafi (@mkmoutafi) 's Twitter Profile
Myrto K. Moutafi

@mkmoutafi

Oncology Fellow @AttikonHospital & ResearchAffiliate @YaleMed| YOC Committee @ESMO|@H_N_C_I_G | MD,PhD @uoaofficial | #biomarkers #immunoonc #ESMOYOC

ID: 1292429412198121472

calendar_today09-08-2020 11:56:20

211 Tweet

342 Takipçi

427 Takip Edilen

Sara Tolaney (@stolaney1) 's Twitter Profile Photo

Attend the 42nd Miami Breast Cancer Conference March 6-9, 2025 -- an incredible mtg in a beautiful location! Use my last name (TOLANEY) to register for free. shorturl.at/IPlky #gotoPER #MBCC25

Matteo Lambertini, MD PhD (@matteolambe) 's Twitter Profile Photo

Finally the #ResearchMatch platform is online...being a priority during my 2-year mandate as #ESMOYOC chair, it is really special to see it live now...thanks a lot Angelika Starzer, all super #YOC team, francescalongo & ESMO - Eur. Oncology Take advantage of this opportunity! OncoAlert Rodrigo Sánchez-Bayona

Finally the #ResearchMatch platform is online...being a priority during my 2-year mandate as #ESMOYOC chair, it is really special to see it live now...thanks a lot <a href="/StarzerAngelika/">Angelika Starzer</a>, all super #YOC team, <a href="/franclongo/">francescalongo</a> &amp; <a href="/myESMO/">ESMO - Eur. Oncology</a>
Take advantage of this opportunity!
<a href="/OncoAlert/">OncoAlert</a> <a href="/Rodrosb/">Rodrigo Sánchez-Bayona</a>
Hongcheng Zhu 祝鸿程 (@drhongchengzhu) 's Twitter Profile Photo

It was a year ago at #ELCC24 in Prague, when I have an opportunity to meet the panel of multidisciplinary group exploring management of N2 NSCLC. Now our review finally out before #ELCC25! Really looking forward the inspirations in Paris this year! ESMO - Eur. Oncology IASLC #ESMOYOC

It was a year ago at #ELCC24 in Prague, when I have an opportunity to meet the panel of multidisciplinary group exploring management of N2 NSCLC. Now our review finally out before #ELCC25! Really looking forward the inspirations in Paris this year! <a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/IASLC/">IASLC</a> #ESMOYOC
ESMO - Eur. Oncology (@myesmo) 's Twitter Profile Photo

📣Join us for the upcoming #ESMOGuidelines Webinar! Dive deep into EGFR-mutated #mNSCLC, resistance mechanisms, and cutting-edge second-line therapies. Expert insights, real-world cases & evidence-based strategies await! 🔗Register now: ow.ly/7k8F50Vlsrm

📣Join us for the upcoming #ESMOGuidelines Webinar! 
Dive deep into EGFR-mutated #mNSCLC, resistance mechanisms, and cutting-edge second-line therapies. Expert insights, real-world cases &amp; evidence-based strategies await! 

🔗Register now: ow.ly/7k8F50Vlsrm
Myrto K. Moutafi (@mkmoutafi) 's Twitter Profile Photo

📢 #ESMOYOC—Join Us! 🌟Elene Mariamidze Hongcheng Zhu 祝鸿程 📍 Foyer #ELCC25 ESMO - Eur. Oncology 🔹 March 26 | 4pm | YO Mentorship From National to International Oncology Societies 🔹 March 27 | 1pm | YO Vesalius Talk Mending the Gender Gap in Oncology 🔹 March 28 | 3pm | YO Clinical Cases

Rodrigo Sánchez-Bayona (@rodrosb) 's Twitter Profile Photo

📣To all breast Young Oncologists! Our Clinical Case discussion is open for submission now! Don’t miss the opportunity to present your clinical case and discuss with experts in person. ESMO - Eur. Oncology Matteo Lambertini, MD PhD Pablo Mando

📣To all breast Young Oncologists!
Our Clinical Case discussion is open for submission now! Don’t miss the opportunity to present your clinical case and discuss with experts in person. 
<a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/matteolambe/">Matteo Lambertini, MD PhD</a> <a href="/PabloMando/">Pablo Mando</a>
EORTC Quality of Life Group (QLG) (@eortc_qlg) 's Twitter Profile Photo

Patient-reported outcome (PRO) data is essential to understand cancer patients’ reality - Jan Geissler addressing the patient’s perspective at the 6th EORTC #QualityofLife conference 🫶🏼 #QoLConf25 #GivingVoice2Patients

Patient-reported outcome (PRO) data is essential to understand cancer patients’ reality - <a href="/jangeissler/">Jan Geissler</a> addressing the patient’s perspective at the 6th <a href="/EORTC/">EORTC</a> #QualityofLife conference 🫶🏼

#QoLConf25 #GivingVoice2Patients
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Cure. A word we rarely use in patients with mBC, for good reasons. Yet, 25 yrs of targeting HER2 taught us that some HER2+ mBCs respond so well to treatment that never reappear. Glad to contribute to this excellent CancerWorld article on the topic: cancerworld.net/its-no-longer-…

Cure. 

A word we rarely use in patients with mBC, for good reasons.

Yet, 25 yrs of targeting HER2 taught us that some HER2+ mBCs respond so well to treatment that never reappear.

Glad to contribute to this excellent <a href="/CancerWorldmag/">CancerWorld</a> article on the topic:
cancerworld.net/its-no-longer-…
Giannis Mountzios (@g_mountzios) 's Twitter Profile Photo

Being part of a history-making drug that helps pts with #SCLC live longer and better is the biggest reward a thoracic oncologist could hope for. Grateful being involved and to our pts Just out in NEJM Presentation today by 1@only Charlie Rudin #ASCO25

Being part of a history-making drug that helps pts with #SCLC live longer and better is the biggest reward a thoracic oncologist could hope for.
Grateful being involved and to our  pts
Just out in <a href="/NEJM/">NEJM</a>
 Presentation today by 1@only <a href="/charlesrudin/">Charlie Rudin</a> 
#ASCO25